{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:30Z","timestamp":1793325690521,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.kint.2022.08.036","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T11:33:18Z","timestamp":1666265598000},"page":"144-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Nidhi","family":"Dwivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeda","family":"Jamadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijo","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2022.08.036_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000494923","article-title":"Analysis of nationwide data to determine the incidence and diagnosed prevalence of autosomal dominant polycystic kidney disease in the USA: 2013-2015","volume":"5","author":"Willey","year":"2019","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.kint.2022.08.036_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes","volume":"1","author":"Grantham","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.08.036_bib4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.08.036_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jcp.1041500220","article-title":"Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia","volume":"150","author":"Wilson","year":"1992","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.kint.2022.08.036_bib6","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2022.08.036_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.4253","article-title":"Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease","volume":"231","author":"Kramann","year":"2013","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.kint.2022.08.036_bib8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2022.08.036_bib9","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1681\/ASN.2006050420","article-title":"Renal fibroblasts and myofibroblasts in chronic kidney disease","volume":"17","author":"Strutz","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.08.036_bib10","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.2020020190","article-title":"Epithelial vasopressin type-2 receptors regulate myofibroblasts by a YAP-CCN2-dependent mechanism in polycystic kidney disease","volume":"31","author":"Dwivedi","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.08.036_bib11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","article-title":"Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD)","volume":"1812","author":"Norman","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2022.08.036_bib12","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2022.08.036_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.kint.2018.06.025","article-title":"CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression","volume":"94","author":"Kleczko","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-59745-352-3_3","article-title":"Propagation and culture of renal fibroblasts","volume":"466","author":"Grimwood","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.kint.2022.08.036_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41419-021-04248-9","article-title":"The tyrosine-kinase inhibitor nintedanib ameliorates autosomal-dominant polycystic kidney disease","volume":"12","author":"Jamadar","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.kint.2022.08.036_bib16","first-page":"464","article-title":"A\u00a0cAMP and CREB-mediated feed-forward mechanism regulates GSK3beta in polycystic kidney disease","volume":"8","author":"Kakade","year":"2016","journal-title":"J\u00a0Mol Cell Biol"},{"key":"10.1016\/j.kint.2022.08.036_bib17","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.3390\/ijms23147601","article-title":"Vasopressin receptor type-2 mediated signaling in renal cell carcinoma stimulates stromal fibroblast activation","volume":"23","author":"Jamadar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2022.08.036_bib18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ki.2014.427","article-title":"Glycogen synthase kinase-3beta promotes cyst expansion in polycystic kidney disease","volume":"87","author":"Tao","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib19","doi-asserted-by":"crossref","first-page":"F650","DOI":"10.1152\/ajprenal.00516.2014","article-title":"Glycogen synthase kinase 3alpha regulates urine concentrating mechanism in mice","volume":"308","author":"Norregaard","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2022.08.036_bib20","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1096\/fj.202000526RR","article-title":"Glycogen synthase kinase-3beta inhibits tubular regeneration in acute kidney injury by a FoxM1-dependent mechanism","volume":"34","author":"Sinha","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2022.08.036_bib21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ki.2012.239","article-title":"Specific deletion of glycogen synthase kinase-3beta in the renal proximal tubule protects against acute nephrotoxic injury in mice","volume":"82","author":"Howard","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib22","first-page":"931","article-title":"Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice","volume":"8","author":"Singh","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.kint.2022.08.036_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41388-019-1059-0","article-title":"Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy","volume":"39","author":"Sinha","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.kint.2022.08.036_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/1541-7786.MCR-13-0543","article-title":"PAI-1 leads to G1-phase cell-cycle progression through cyclin D3\/cdk4\/6 upregulation","volume":"12","author":"Giacoia","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.kint.2022.08.036_bib25","doi-asserted-by":"crossref","first-page":"42905","DOI":"10.18632\/oncotarget.5466","article-title":"Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase\/AKT, and ERK1\/2 independent of MMP inhibition in lung adenocarcinoma cells","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2022.08.036_bib26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.biopha.2018.08.083","article-title":"Expression and significance of cystatin-C in clear cell renal cell carcinoma","volume":"107","author":"Guo","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.kint.2022.08.036_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.bjc.6601533","article-title":"Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase","volume":"90","author":"Porter","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.kint.2022.08.036_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41536-021-00153-z","article-title":"The bright side of fibroblasts: molecular signature and regenerative cues in major organs","volume":"6","author":"Gomes","year":"2021","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.kint.2022.08.036_bib29","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3892\/ol.2017.6497","article-title":"Cancer associated fibroblasts: an essential role in the tumor microenvironment","volume":"14","author":"Tao","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.kint.2022.08.036_bib30","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.ejca.2013.06.032","article-title":"Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin","volume":"49","author":"Bakhtyar","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.kint.2022.08.036_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169105","article-title":"The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases","volume":"11","author":"Errarte","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2022.08.036_bib32","first-page":"768","article-title":"Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis","volume":"52","author":"Kaminska","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.kint.2022.08.036_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.humpath.2016.03.009","article-title":"Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma","volume":"54","author":"Lopez","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.kint.2022.08.036_bib34","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1158\/0008-5472.CAN-10-2279","article-title":"Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression","volume":"70","author":"Lopez-Lago","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2022.08.036_bib35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1586\/14737140.2015.1110488","article-title":"Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma","volume":"15","author":"Massari","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.kint.2022.08.036_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.kint.2018.10.017","article-title":"Myofibroblasts acquire retinoic acid-producing ability during fibroblast-to-myofibroblast transition following kidney injury","volume":"95","author":"Nakamura","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib37","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/labinvest.2017.97","article-title":"Deletion of Pkd1 in renal stromal cells causes defects in the renal stromal compartment and progressive cystogenesis in the kidney","volume":"97","author":"Nie","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.kint.2022.08.036_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","article-title":"Inflammation and fibrosis in polycystic kidney disease","volume":"60","author":"Song","year":"2017","journal-title":"Results Probl Cell Differ"},{"key":"10.1016\/j.kint.2022.08.036_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.kint.2022.08.036_bib41","first-page":"C106","article-title":"An integrative view of serpins in health and disease: the contribution of SerpinA3","volume":"320","author":"Sanchez-Navarro","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2022.08.036_bib42","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ki.2013.13","article-title":"Cyst expansion and regression in a mouse model of polycystic kidney disease","volume":"83","author":"Happe","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib43","doi-asserted-by":"crossref","first-page":"648134","DOI":"10.3389\/fgene.2022.648134","article-title":"TIMP1 indicates poor prognosis of renal cell carcinoma and accelerates tumorigenesis via EMT signaling pathway","volume":"13","author":"Shou","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.kint.2022.08.036_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000013552","article-title":"Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease","volume":"20","author":"Nakamura","year":"2000","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2022.08.036_bib45","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/gerona\/61.11.1130","article-title":"TIMP-1 promotes age-related renal fibrosis through upregulating ICAM-1 in human TIMP-1 transgenic mice","volume":"61","author":"Zhang","year":"2006","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.kint.2022.08.036_bib46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1160\/TH08-12-0779","article-title":"Serine proteases, inhibitors and receptors in renal fibrosis","volume":"101","author":"Eddy","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2022.08.036_bib47","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/ndt\/gfz050","article-title":"Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction","volume":"34","author":"Yao","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2022.08.036_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s004670000461","article-title":"Molecular basis of renal fibrosis","volume":"15","author":"Eddy","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2022.08.036_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MNH.0b013e3283521cfa","article-title":"Renal interstitial fibrosis: mechanisms and evaluation","volume":"21","author":"Farris","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2022.08.036_bib50","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/onc.2017.65","article-title":"Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of chitinase 3-like 1","volume":"36","author":"Cohen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.kint.2022.08.036_bib51","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","article-title":"Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells","volume":"75","author":"Lo","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2022.08.036_bib52","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2022.08.036_bib53","first-page":"125","article-title":"Autosomal dominant polycystic kidney disease: cellular and molecular mechanisms of cyst formation","volume":"21","author":"Wilson","year":"1992","journal-title":"Adv Nephrol Necker Hosp"},{"key":"10.1016\/j.kint.2022.08.036_bib54","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst\u00a0growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.08.036_bib55","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13951","article-title":"Urinary T cells correlate with rate of renal function loss in autosomal dominant polycystic kidney disease","volume":"7","author":"Zimmerman","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1016\/j.kint.2022.08.036_bib56","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease progression","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.08.036_bib57","doi-asserted-by":"crossref","first-page":"109647","DOI":"10.1016\/j.cellsig.2020.109647","article-title":"Role of chemokines, innate and adaptive immunity","volume":"73","author":"Zimmerman","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2022.08.036_bib58","doi-asserted-by":"crossref","first-page":"109646","DOI":"10.1016\/j.cellsig.2020.109646","article-title":"Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease","volume":"72","author":"Zhang","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2022.08.036_bib59","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.3390\/ijms21238936","article-title":"The controversial role of fibrosis in autosomal dominant polycystic kidney disease","volume":"21","author":"Fragiadaki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2022.08.036_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2017.07.010","article-title":"Drug targeting to myofibroblasts: implications for fibrosis and cancer","volume":"121","author":"Yazdani","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.kint.2022.08.036_bib61","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Ozdemir","year":"2014","journal-title":"Cancer Cell"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253822008419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253822008419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:04:46Z","timestamp":1758762286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253822008419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0085253822008419"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2022.08.036","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2022.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}